{"date":"2025-04-10","count":27,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6634-2025-04-10-2105-1k91zkl","company_id":"6634","company":"欣耀","market":"興櫃","industry":"生技醫療","date":"2025-04-10","time":"21:05:41","subject":"本公司高肝安全性乙醯胺酚止痛新藥SNP-810(安泰拿疼)合併不成癮止劇痛藥於換膝手術病人肝安全性及術後疼痛控制臨床試驗取得試驗最終報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：欣耀（6634），2025-04-10 21:05，「本公司高肝安全性乙醯胺酚止痛新藥SNP-810(安泰拿疼)合併不成癮止劇痛藥於換膝手術病人肝安全性及術後疼痛控制臨床試驗」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1795-2025-04-10-2022-1rhzb7m","company_id":"1795","company":"美時","market":"上市","industry":"生技醫療","date":"2025-04-10","time":"20:22:39","subject":"公告本公司董事會決議買回庫藏股轉讓予員工","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：美時（1795），2025-04-10 20:22，「公告本公司董事會決議買回庫藏股轉讓予員工」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6576-2025-04-10-1824-5imj07","company_id":"6576","company":"逸達","market":"上櫃","industry":"生技醫療","date":"2025-04-10","time":"18:24:17","subject":"本公司代理發言人異動","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：逸達（6576），2025-04-10 18:24，「本公司代理發言人異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6539-2025-04-10-1821-1hku5w3","company_id":"6539","company":"麗彤","market":"興櫃","industry":"生技醫療","date":"2025-04-10","time":"18:21:05","subject":"公告本公司董事會通過113年度合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：麗彤（6539），2025-04-10 18:21，「公告本公司董事會通過113年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6892-2025-04-10-1816-1n7lnw","company_id":"6892","company":"台寶生醫","market":"興櫃","industry":"生技醫療","date":"2025-04-10","time":"18:16:59","subject":"本公司美國子公司PhiBio Therapeutics Inc.自體細胞新藥TRK-001預防活體腎臟移植受贈者排斥反應之二期臨床試驗計畫，接獲衛生福利部通知臨床試驗執行醫院與製造場所GTP訪查結果核可","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：台寶生醫（6892），2025-04-10 18:16，「本公司美國子公司PhiBio Therapeutics Inc.自體細胞新藥TRK-001預防活體腎臟移植受贈者排斥反應」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6539-2025-04-10-1805-1mvikll","company_id":"6539","company":"麗彤","market":"興櫃","industry":"生技醫療","date":"2025-04-10","time":"18:05:45","subject":"113年下半年度盈餘分派案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：麗彤（6539），2025-04-10 18:05，「113年下半年度盈餘分派案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6539-2025-04-10-1801-c26dl8","company_id":"6539","company":"麗彤","market":"興櫃","industry":"生技醫療","date":"2025-04-10","time":"18:01:51","subject":"公告本公司董事會決議召開114年股東常會事宜(新增議案)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：麗彤（6539），2025-04-10 18:01，「公告本公司董事會決議召開114年股東常會事宜(新增議案)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6539-2025-04-10-1801-r0m69i","company_id":"6539","company":"麗彤","market":"興櫃","industry":"生技醫療","date":"2025-04-10","time":"18:01:30","subject":"公告本公司董事會決議註銷庫藏股及訂定減資基準日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：麗彤（6539），2025-04-10 18:01，「公告本公司董事會決議註銷庫藏股及訂定減資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6539-2025-04-10-1801-1gun75k","company_id":"6539","company":"麗彤","market":"興櫃","industry":"生技醫療","date":"2025-04-10","time":"18:01:09","subject":"盈餘轉增資發行新股","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：麗彤（6539），2025-04-10 18:01，「盈餘轉增資發行新股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6539-2025-04-10-1800-1o40ttn","company_id":"6539","company":"麗彤","market":"興櫃","industry":"生技醫療","date":"2025-04-10","time":"18:00:34","subject":"113年下半年度盈餘股利配發基準日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：麗彤（6539），2025-04-10 18:00，「113年下半年度盈餘股利配發基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7803-2025-04-10-1713-2iz4hx","company_id":"7803","company":"雲象科技-創","market":"上市","industry":"生技醫療","date":"2025-04-10","time":"17:13:10","subject":"公告本公司董事會決議不發放股利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：雲象科技-創（7803），2025-04-10 17:13，「公告本公司董事會決議不發放股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7803-2025-04-10-1700-1hku5w3","company_id":"7803","company":"雲象科技-創","market":"上市","industry":"生技醫療","date":"2025-04-10","time":"17:00:57","subject":"公告本公司董事會通過113年度合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：雲象科技-創（7803），2025-04-10 17:00，「公告本公司董事會通過113年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7803-2025-04-10-1700-tulf6t","company_id":"7803","company":"雲象科技-創","market":"上市","industry":"生技醫療","date":"2025-04-10","time":"17:00:41","subject":"公告本公司董事會決議召開114年股東常會相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：雲象科技-創（7803），2025-04-10 17:00，「公告本公司董事會決議召開114年股東常會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4743-2025-04-10-1656-pjxkzr","company_id":"4743","company":"合一","market":"上櫃","industry":"生技醫療","date":"2025-04-10","time":"16:56:48","subject":"本公司向美國FDA提出Bonvadis外用乳膏全皮層慢性傷口適應症510(k)醫材申請","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：合一（4743），2025-04-10 16:56，「本公司向美國FDA提出Bonvadis外用乳膏全皮層慢性傷口適應症510(k)醫材申請」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4172-2025-04-10-1655-e6f4eb","company_id":"4172","company":"因華","market":"興櫃","industry":"生技醫療","date":"2025-04-10","time":"16:55:50","subject":"公告本公司新藥D07001軟膠囊劑之晚期膽道癌患者之二三期臨床試驗，其第一階段業經安全性評估委員會(SRC)審查，已完成受試者納入及併用安全性評估，本階段試驗完成","clause":"第44款","fact_date":"2025-04-10","cite_as":"公開資訊觀測站重大訊息：因華（4172），2025-04-10 16:55，「公告本公司新藥D07001軟膠囊劑之晚期膽道癌患者之二三期臨床試驗，其第一階段業經安全性評估委員會(SRC)審查，已完成」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4743-2025-04-10-1644-r20q1u","company_id":"4743","company":"合一","market":"上櫃","industry":"生技醫療","date":"2025-04-10","time":"16:44:01","subject":"公告本公司董事會決議處分(轉租)部分不動產使用權資產予關係人","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：合一（4743），2025-04-10 16:44，「公告本公司董事會決議處分(轉租)部分不動產使用權資產予關係人」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4743-2025-04-10-1642-1xtf1o0","company_id":"4743","company":"合一","market":"上櫃","industry":"生技醫療","date":"2025-04-10","time":"16:42:32","subject":"公告本公司董事會決議向關係人取得部分不動產使用權資產","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：合一（4743），2025-04-10 16:42，「公告本公司董事會決議向關係人取得部分不動產使用權資產」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6876-2025-04-10-1616-1qtka21","company_id":"6876","company":"朗齊生醫*","market":"興櫃","industry":"生技醫療","date":"2025-04-10","time":"16:16:24","subject":"公告本公司董事會選任副董事長","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：朗齊生醫*（6876），2025-04-10 16:16，「公告本公司董事會選任副董事長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6876-2025-04-10-1615-1rpjgd9","company_id":"6876","company":"朗齊生醫*","market":"興櫃","industry":"生技醫療","date":"2025-04-10","time":"16:15:35","subject":"公告本公司董事會之議決事項，未經審計委員會通過，而經全體董事三分之二以上同意通過者","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：朗齊生醫*（6876），2025-04-10 16:15，「公告本公司董事會之議決事項，未經審計委員會通過，而經全體董事三分之二以上同意通過者」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6876-2025-04-10-1614-80b0m0","company_id":"6876","company":"朗齊生醫*","market":"興櫃","industry":"生技醫療","date":"2025-04-10","time":"16:14:13","subject":"公告本公司董事會決議不再繼續辦理113年私募普通股案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：朗齊生醫*（6876），2025-04-10 16:14，「公告本公司董事會決議不再繼續辦理113年私募普通股案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6876-2025-04-10-1613-1s04pqb","company_id":"6876","company":"朗齊生醫*","market":"興櫃","industry":"生技醫療","date":"2025-04-10","time":"16:13:02","subject":"公告本公司董事會決議召開114年股東常會(新增議案)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：朗齊生醫*（6876），2025-04-10 16:13，「公告本公司董事會決議召開114年股東常會(新增議案)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7790-2025-04-10-1552-ub84r7","company_id":"7790","company":"思必瑞特","market":"興櫃","industry":"生技醫療","date":"2025-04-10","time":"15:52:05","subject":"公告本公司114年第一次股東臨時會重要決議事項","clause":"第15款","fact_date":"2025-04-10","cite_as":"公開資訊觀測站重大訊息：思必瑞特（7790），2025-04-10 15:52，「公告本公司114年第一次股東臨時會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6637-2025-04-10-1547-m9oa22","company_id":"6637","company":"醫影","market":"上櫃","industry":"生技醫療","date":"2025-04-10","time":"15:47:00","subject":"公告本公司訂定114年現金增資認股基準日等相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：醫影（6637），2025-04-10 15:47，「公告本公司訂定114年現金增資認股基準日等相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1786-2025-04-10-1534-1hqsogb","company_id":"1786","company":"科妍","market":"上市","industry":"生技醫療","date":"2025-04-10","time":"15:34:33","subject":"公告本公司調整配息率","clause":"第14款","fact_date":"2025-04-10","cite_as":"公開資訊觀測站重大訊息：科妍（1786），2025-04-10 15:34，「公告本公司調整配息率」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6838-2025-04-10-1521-lnj9s3","company_id":"6838","company":"台新藥","market":"上市","industry":"生技醫療","date":"2025-04-10","time":"15:21:24","subject":"公告本公司初次申請股票上市時所出具之承諾事項執行情形","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：台新藥（6838），2025-04-10 15:21，「公告本公司初次申請股票上市時所出具之承諾事項執行情形」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6130-2025-04-10-1405-13fqnxr","company_id":"6130","company":"上亞科技","market":"上櫃","industry":"生技醫療","date":"2025-04-10","time":"14:05:13","subject":"公告本公司法人董事-星寶電子科技股份有限公司改派代表人","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：上亞科技（6130），2025-04-10 14:05，「公告本公司法人董事-星寶電子科技股份有限公司改派代表人」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6919-2025-04-10-1139-1i886is","company_id":"6919","company":"康霈*","market":"上市","industry":"生技醫療","date":"2025-04-10","time":"11:39:35","subject":"公告調整本公司112年度董事酬金申報作業公告之金額單位","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：康霈*（6919），2025-04-10 11:39，「公告調整本公司112年度董事酬金申報作業公告之金額單位」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}